Skip to main content
 
File #: 250879    Version: 1 Name: Settlement of Unlitigated Claims against Alvogen, Inc., et al. - City to Receive Approximately $1,200,000 to $2,000,000 Over 10 Years
Type: Resolution Status: Pending Committee Action
Introduced: 9/2/2025 In control: Government Audit and Oversight Committee
On agenda: 9/2/2025 Final action:
Enactment date: Enactment #:
Title: Resolution authorizing settlement of unlitigated claims on behalf of the City and County of San Francisco and the People of the State of California against Alvogen, Inc.; Amneal Pharmaceuticals, Inc.; Apotex Inc.; Hikma Pharmaceuticals USA Inc.; Indivior Inc.; Mylan Pharmaceuticals Inc.; Sun Pharmaceutical Industries, Inc.; and Zydus Pharmaceuticals (USA), Inc. for abatement funds in the range of $1,200,000 to $2,000,000 to be paid over 10 years; the claims relate to settling companies’ allegedly improper and unlawful practices, which contributed to the epidemic of opioid abuse and misuse and caused a public nuisance.
Attachments: 1. Leg Ver1
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.